TransMedics Group, Inc. (TMDX)
91.37
-0.63
(-0.68%)
USD |
NASDAQ |
Nov 13, 16:00
90.10
-1.27
(-1.39%)
After-Hours: 19:59
TransMedics Group Gross Profit Margin (Quarterly) : 56.20% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 56.20% |
| June 30, 2026 | 57.34% |
| March 31, 2026 | 57.07% |
| December 31, 2025 | 58.11% |
| September 30, 2025 | 58.74% |
| June 30, 2025 | 61.31% |
| March 31, 2025 | 61.40% |
| December 31, 2024 | 59.21% |
| September 30, 2024 | 55.85% |
| June 30, 2024 | 60.51% |
| March 31, 2024 | 61.81% |
| December 31, 2023 | 59.04% |
| September 30, 2023 | 61.21% |
| June 30, 2023 | 70.03% |
| March 31, 2023 | 69.23% |
| December 31, 2022 | 65.99% |
| September 30, 2022 | 70.53% |
| June 30, 2022 | 69.93% |
| March 31, 2022 | 76.22% |
| December 31, 2021 | 72.26% |
| Date | Value |
|---|---|
| September 30, 2021 | 70.26% |
| June 30, 2021 | 68.40% |
| March 31, 2021 | 68.21% |
| December 31, 2020 | 63.30% |
| September 30, 2020 | 71.05% |
| June 30, 2020 | 56.30% |
| March 31, 2020 | 64.54% |
| December 31, 2019 | 61.76% |
| September 30, 2019 | 58.51% |
| June 30, 2019 | 58.82% |
| March 31, 2019 | 55.03% |
| December 31, 2018 | 42.30% |
| September 30, 2018 | 52.79% |
| June 30, 2018 | 40.45% |
| March 31, 2018 | 36.68% |
| December 31, 2017 | 25.07% |
| September 30, 2017 | 26.03% |
| June 30, 2017 | 36.34% |
| March 31, 2017 | 21.08% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp. | 62.20% |
| Insulet Corp. | 75.51% |
| Abbott Laboratories | 50.36% |
| Baxter International, Inc. | 33.30% |
| Becton, Dickinson & Co. | 51.06% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 30.21% |
| Return on Assets | 11.14% |
| Return on Invested Capital | 11.98% |
| Profit Margin (Quarterly) | 8.41% |
| Operating Margin (Quarterly) | 14.19% |
| Return on Net Operating Assets | 20.24% |